Published in Z Rheumatol on November 01, 2005
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum (2000) 8.64
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum (2004) 7.79
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum (2002) 5.33
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum (2002) 4.77
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum (2004) 3.38
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis (2003) 3.33
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis (2004) 3.23
Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther (2005) 3.17
Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum (2003) 2.97
Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum (2000) 2.92
The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. Rheumatology (Oxford) (2003) 2.79
Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis (2004) 2.71
Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum (2003) 2.59
Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis (2003) 2.53
Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol (1993) 2.40
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis (2002) 2.13
Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis (1998) 2.09
Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum (2001) 2.00
Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum (2002) 1.87
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol (1995) 1.77
Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum (2002) 1.75
Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum (1996) 1.73
[Imaging techniques in rheumatology: sonography in rheumatoid arthritis]. Z Rheumatol (2003) 1.73
Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum (2002) 1.58
Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum (2003) 1.56
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study. J Rheumatol (1988) 1.53
Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum (1995) 1.44
Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum (1999) 1.42
New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum (2003) 1.40
Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Arthritis Rheum (2001) 1.38
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol (2000) 1.37
Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis (2001) 1.34
What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis (2001) 1.30
A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ (1996) 1.25
Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. J Rheumatol (2003) 1.20
Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum (1996) 1.17
The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum (1993) 1.15
Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis (2002) 1.14
The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.14
Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Radiology (2000) 1.10
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis (1998) 1.10
[Imaging techniques in rheumatology: magnetic resonance imaging in rheumatoid arthritis]. Z Rheumatol (2003) 1.08
Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum (2002) 1.07
Early arthritis therapy: rationale and current approach. J Rheumatol Suppl (1998) 1.03
How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol (2005) 0.99
Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive? Br J Rheumatol (1995) 0.99
Ultrasonography detection of early bone erosions in the metacarpophalangeal joints of patients with rheumatoid arthritis. Clin Exp Rheumatol (2005) 0.96
Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol (2005) 0.95
One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline. J Rheumatol (2000) 0.95
Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. J Rheumatol (2003) 0.94
Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis. Br J Rheumatol (1997) 0.91
An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis: performance over five years in a primary care-based prospective study. Arthritis Rheum (2005) 0.89
[Synovial membrane diagnostic assessment in rheumatoid arthritis]. Z Rheumatol (2002) 0.86
Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs. J Rheumatol (2004) 0.82
The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. J Rheumatol (1994) 0.81
Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann Rheum Dis (2005) 1.15
[Capillaroscopy. Procedure and nomenclature]. Z Rheumatol (2010) 1.06
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils. Rheumatology (Oxford) (2008) 1.02
[Sensitivity and significance of nuclear magnetic tomography findings of finger joints in rheumatoid arthritis]. Z Rheumatol (2002) 0.84
Detecting new Buffel grass infestations in Australian arid lands: evaluation of methods using high-resolution multispectral imagery and aerial photography. Environ Monit Assess (2014) 0.82
Autoantibodies to human tissue transgutaminase identify silent coeliac disease in Type I diabetes. Diabetologia (1999) 0.81
Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease. Ann Rheum Dis (2009) 0.80
"Bubbles in the brain": an unusual complication of dermatomyositis. Ann Rheum Dis (2006) 0.80
[Magnetic resonance angiography in rheumatology]. Z Rheumatol (2012) 0.80
[Case-based interactive PACS learning: introduction of a new concept for radiological education of students]. Radiologe (2011) 0.79
Expression of CD57 on CD8+ T lymphocytes of patients with Wegener's granulomatosis and microscopic polyangiitis: evidence for continuous activation of CD8+ cells. Clin Exp Rheumatol (2009) 0.78
Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes. Diabetologia (2000) 0.77
[Cartilage quality in finger joints: delayed Gd(DTPA)²-enhanced MRI of the cartilage (dGEMRIC) at 3T]. Rofo (2010) 0.77
[MR-morphological changes of the metacarpophalangeal joints in patients with rheumatoid arthritis: Comparison of early and chronical stages]. Rofo (2001) 0.76
[Bony pathologies of the metacarpophalangeal joints in early rheumatoid arthritis: comparison of MRI and high-resolution SPECT]. Rofo (2009) 0.76
Intra-individual assessment of inflammatory severity and cartilage composition of finger joints in rheumatoid arthritis. Skeletal Radiol (2014) 0.76
[Bullous systemic lupus erythematosus]. Hautarzt (2004) 0.75
[Hypovolemic shock associated with generalized edema: paroxysmal non-hereditary angioedema (Clarkson syndrome)]. Dtsch Med Wochenschr (2000) 0.75
[Treat-to-target and remission: current strategies in rheumatoid arthritis]. Dtsch Med Wochenschr (2012) 0.75
[Magnetic resonance tomography and hybrid imaging in rheumatology]. Z Rheumatol (2013) 0.75
["Second opinion" in online radiology via Internet: report on implementation and analysis of reliability of findings in sectional images]. Aktuelle Radiol (1997) 0.75
Finger joint swellings in a teenager: juvenile rheumatoid arthritis or a psychiatric disorder? Ann Rheum Dis (2005) 0.75
[Imaging in rheumatology]. Z Rheumatol (2013) 0.75
[Imaging methods in rheumatology: imaging in psoriasis arthritis (PsA)]. Z Rheumatol (2006) 0.75